Keystone Symposia

Keystone Symposia Scientific Advisory Board

The Scientific Advisory Board (SAB) is comprised of eminent biomedical scientists whose expertise derives from academia, industry, and the government. The SAB is tasked with guiding the development of the conference portfolio, prioritizing content and topics, and providing a substantive peer review process to ensure Keystone Symposia's reputation as the preeminent convener of scientific conferences in the biomedical and life sciences.

To learn more about the functions of the SAB, please click here.

Board of Directors are denoted with a # following their name.

E. Dale Abel, M.D., Ph.D.#
William S. Adams Professor of Medicine
Chair and Executive Medical Director
Department of Medicine
David Geffen School of Medicine and UCLA Health

Clement Adebamowo, B.M., Ch.B., Hons, Sc.D.
Professor Epidemiology and Public Health
Associate Director Population Science,
Greenebaum Comprehensive Cancer Center
Member, Institute of Human Virology
University of Maryland School of Medicine

Karen Adelman, Ph.D.
Biological Chemistry and Molecular Pharmacology
Harvard Medical School

Luciano Adorini, M.D.
Chief Scientific Officer
Preclinical Research
Intercept Pharmaceuticals, Inc.

Muhammad Al-Hajj, Ph.D.
Chief Scientific Officer
IO Biotech ApS

Zoltan Arany, M.D., Ph.D.
University of Pennsylvania

Eric H. Baehrecke, Ph.D.
Molecular, Cell and Cancer Biology
University of Massachusetts Medical School

Yasmine Belkaid, Ph.D.
Director NIAID Microbiome Program
Chief Mucosal Immunology Section
Laboratory of Parasitic Disease
NIAID, National Institutes of Health

Lawrence Bloch, M.D.
Infinity Pharmaceuticals, Inc.

Ralph A. Bradshaw, Ph.D.#
Professor Emeritus
Department of Physiology and Biophysics
University of California, Irvine

Cherié L. Butts, Ph.D.#
Medical Director
Digital & Quantitative Medicine
Biogen Inc

Robert Califf, M.D., MACC#
Head of Medical Strategy and Policy for Verily and Google Health
Verily Life Sciences, Google Health

Ian M. Colrain, Ph.D.#
President SRI International
SRI Biosciences

Roger D. Cone, Ph.D.
Life Sciences Institute
University of Michigan

Feng Cong, Ph.D.
Chemical Biology & Therapeutics
Novartis Institutes for BioMedical Research

John E. Connolly, Ph.D.
Chief Scientific Officer, Parker Institute for Cancer Immunotherapy
Senior Principal Investigator and Director for Translational Immunology, Institute of Molecular and Cell Biology

Ana Maria Cuervo, M.D., Ph.D.
Professor, Department of Developmental and Molecular Biology
Co-Director, Institute for Aging Studies
Albert Einstein College of Medicine

Robertus de Bruin, Ph.D.
Professor, Molecular Cancer Biology
MRC Laboratory for Molecular Cell Biology
University College London

Robert J. Deans, Ph.D.
Chief Scientific Officer
Synthego Corporation

Russell A. DeBose-Boyd, Ph.D.
Molecular Genetics
University of Texas Southwestern Medical Center

Edward A. Dennis, Ph.D.#
Chancellor Distinguished Professor
Chemistry, Biochemistry and Pharmacology
School of Medicine
University of California, San Diego

Suzanne Devkota, Ph.D.
Assistant Professor
Karsh Division of Gastroenterology
Cedars-Sinai Medical Center

Aris N. Economides, Ph.D.
Vice President
Regeneron Pharmaceuticals, Inc.

Sandra J. Engle, Ph.D.
Senior Director
Translational Biology
Biogen, Inc.

Patrick Finn, Ph.D.
Senior Director
Rare Diseases

Kelly A. Frazer, Ph.D.
Professor, Pediatrics
Director, Institute for Genomic Medicine
University of California San Diego School of Medicine

Maria C. Freire#
President and Executive Director
Foundation for the National Institutes of Health (FNIH)

Mattias Fyrenius#
Publishing Director
Bonnier Carlsen

Dmitry I. Gabrilovich, M.D., Ph.D.
Chief Scientist
Cancer Immunology

Stephan Gasser, Ph.D.
Senior Principal Scientist
Roche Innovation Center Zurich

Geoffrey S. Ginsburg, M.D., Ph.D.
The Duke Center for Applied Genomics & Precision Medicine
Duke University

Margaret A. Goodell, Ph.D.#
Professor and Chair
Department of Molecular and Cellular Biology
Director of Stem Cells & Regenerative Medicine Center
Vivian L. Smith Chair of Regenerative Medicine
Baylor College of Medicine

Curtis C. Harris, M.D.#
Chief, Laboratory of Human Carcinogenesis
NCI / National Institutes of Health

Lora K. Heisler, Ph.D.
Chair in Human Nutrition
Obesity and Food Choice
Rowett Institute, University of Aberdeen

Sean Hill, Ph.D.
Director, Krembil Centre for Neuroinformatics
Centre for Addiction and Mental Health
Professor, Department of Psychiatry, University of Toronto
Professor, Blue Brain Project, École Polytechnique Fédérale de Lausanne (EPFL)

Jonathan Hill, Ph.D.
Senior Director
Surface Oncology

Robert J. Hofmeister, Ph.D.
Chief Scientific Officer
TCR2 Therapeutics

Robert E. Hollingsworth, Ph.D.
Vice President
Oncology Research and Development

Michael J. Holtzman, M.D.
Selman and Herman Seldin Professor, Medicine
Director, Pulmonary and Critical Care Medicine
Professor, Cell Biology and Physiology
Washington University in St. Louis
President, NuPeak Therapeutics

Tony Hunter, Ph.D.#
Professor and Principal Investigator
Molecular Cellular Biology Laboratories
The Salk Institute for Biological Sciences

Stefan Irion, M.D.
Vice President CNS Research
BlueRock Therapeutics

Aron B. Jaffe, Ph.D.
Senior Vice President, Head of Research
Chroma Medicine

Thale C. Jarvis, Ph.D.#
Chief Scientific Officer
Keystone Symposia

Deborah L. Johnson, Ph.D.#
President and Chief Executive Officer
Keystone Symposia on Molecular and Cellular Biology

Véronique Kiermer, Ph.D.#
Chief Scientific Officer
Public Library of Science (PLOS)

Katherine W. Klinger, Ph.D.
Global Head
Translational Sciences

Tony K.T. Lam, Ph.D.
Professor and J.K. McIvor Endowed Chair in Diabetes Research
Canada Research Chair in Obesity
Associate Director, Banting and Best Diabetes Centre
Advanced Diagnostics and Metabolism
Toronto General Research Institute

Dangsheng Li, Ph.D.
Deputy Editor-in-Chief
Cell Research
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences

Jean K. Lim, Ph.D.
Associate Professor
Icahn School of Medicine at Mount Sinai

Juan Carlos Lopez, Ph.D.#
Haystack Science

Patrick Mayes, Ph.D.
Executive Director
Immuno-Oncology Antibodies
Incyte Research Institute

M. Juliana McElrath, M.D., Ph.D.
Senior Vice President, Director and Member
Vaccine and Infectious Disease Division
Fred Hutchinson Cancer Research Center

Laura F. Michael, Ph.D.
Senior Director
Diabetes and Complications Therapeutic Area
Eli Lilly and Company

Valerie Mizrahi, Ph.D.
Institute of Infectious Disease and Molecular Medicine (IDM)
University of Cape Town

Craig Monell, Ph.D.
Vice President
Business Operations/R&D
BioLegend, Inc.

Walter H. Moos, Ph.D.#
Managing Director, Pandect Bioventures
Professor (adj), University of California, San Francisco
President (ret), SRI Biosciences, Stanford Research Institute
Chairman (emer), ShangPharma Innovation

Richard A. Morgan, Ph.D.
Chief Scientific Officer
Be Biopharma

Lily Y. Moy, Ph.D.
Director, Pharmacology
Quantitative Biosciences
Merck & Co.

Leon O. Murphy, Ph.D.
Chief Scientific Officer
Casma Therapeutics

Lee A. Niswander, Ph.D.
Professor and Chair
Molecular, Cellular and Developmental Biology
University of Colorado Boulder

Anne O'Garra, Ph.D., FRS, FMedSci#
Senior Group Leader
The Francis Crick Institute

Deborah Palliser, Ph.D.
Immunology Strategy Lead
Rare Diseases Drug Discovery Unit

Paul W. H. I. Parren, Ph.D.
Department of Immunohematology and Blood Transfusion
Leiden University Medical Center

Mark J. Powers, Ph.D.
Senior Director, Research and Development- Cell Biology
Thermo Fisher Scientific

Bali Pulendran, Ph.D.
Professor, Pathology and of Microbiology and Immunology
Stanford University School of Medicine

Michael H. Rabinowitz, Ph.D.
Vice President
Akebia Therapeutics, Inc

Laszlo Radvanyi, Ph.D.
President and Scientific Director
Ontario Institute for Cancer Research

Richard M. Ransohoff, M.D.
Venture Partner
Third Rock Ventures

Rino Rappuoli, Ph.D.
Chief Scientist and Head of External Research and Development
GlaxoSmithKline Vaccines

Bing Ren, Ph.D.
Ludwig Institute for Cancer Research

Christopher J. Rhodes, BSc, PhD
Chief Scientist, Cardiovascular, Renal & Metabolism, BioPharmaceuticals R&D, AstraZeneca
Professor, University of Chicago

Frank Rigo, Ph.D.
Vice President
Functional Genomics and Drug Discovery
Ionis Pharmaceuticals

Mark Rolfe, Ph.D.
Senior Vice President
Oncogenesis Thematic Research Center
Bristol Myers Squibb

Pamela C. Ronald, Ph.D.
Distinguished Professor
Plant Pathology and the Genome Center
University of California, Davis

Deepak Sampath, Ph.D.
Vice President, Head of Research

Thomas J. Schuetz, M.D., Ph.D.
Co-Founder, Chief Executive Officer, Director
Compass Therapeutics

Janine Schuurman, Ph.D.
Corporate Vice President
Research and Innovation

Ali Shilatifard, Ph.D.
Robert Francis Furchgott Professor
Chairman, Department of Biochemistry and Molecular Genetics
Northwestern University Feinberg School of Medicine

Barry P. Sleckman, M.D., Ph.D.
Director, O'Neal Comprehensive Cancer Center
University of Alabama Birmingham School of Medicine

Hans Ulrich Stilz, Ph.D.
Vice President
R&D Innovation and Outreach
Novo Nordisk A/S

Boris Striepen, Ph.D.
Professor of Microbiology and Immunology
Department of Pathobiology
School of Veterinary Medicine
University of Pennsylvania

Lynda M. Stuart, M.D., Ph.D.
Deputy Director
Global Health, Discovery & Translational Sciences
Bill & Melinda Gates Foundation

Lori Sussel, Ph.D.#
Professor and Director of Research
Basic and Translational Research Division, Barbara Davis Center
University of Colorado Anschutz Medical Campus

Paul K.H. Tam, ChM
Li Shu-Pui Professor and Chair of Pediatric Surgery
Department of Surgery
Director, Dr. Li Dak Sum Research Centre
The University of Hong Kong-Karolinska Institutet Collaboration in Regenerative Medicine

Cormac Taylor, Ph.D.
Professor, Cellular Physiology
University College Dublin

Kathrin Tissot, M.D., Ph.D.
Business Team Head
MorphoSys AG

Cornelia Liu Trimble, M.D.
Gynecology and Obstetrics, Oncology, and Pathology
Johns Hopkins University School of Medicine

Fred Van Goor, Ph.D.
Principal Research Fellow
Vertex Pharmaceuticals Incorporated

Yibin Wang, Ph.D.
Cardiovascular and Metabolic Diseases
Duke-NUS Medical School

Stephanie Wengert Watts, Ph.D.
Professor, Assistant Dean
Pharmacology & Toxicology
Michigan State University

Mary E. Wilson, M.D.
Internal Medicine and Microbiology & Immunology
University of Iowa and the Iowa City VA Medical Center

Joseph C. Wu, M.D., Ph.D.
Professor and Director of Stanford Cardiovascular Institute
Medicine and Radiology
Stanford University School of Medicine

Xuebiao Yao, Ph.D.
Professor and Head
Cellular Dynamics
University of Science & Technology of China

Jonathan Zalevsky, Ph.D.
Chief Research & Development Officer
Nektar Therapeutics

Bei B. Zhang, Ph.D.#
Vice President, Metabolic Research
Worldwide Research and Development
Internal Medicine
Pfizer Inc.

Juleen R. Zierath, Ph.D.#
Department of Molecular Medicine and Surgery
Karolinska Institutet

Arturo Zychlinsky, Ph.D.
Cellular Microbiology
Max Planck Institute for Infection Biology

plus representatives to be announced from:
AbbVie Inc.
Amgen Inc.
Bayer AG
Boehringer Ingelheim Pharmaceuticals, Inc.
Genentech, Inc.
Gilead Sciences, Inc.
Wave Life Sciences USA, Inc.